Apr 26, 2024

Public workspaceEnterovirus D68 3C protease small scale expression and purification protocol

Forked from a private protocol
  • 1Center of Medicines Discovery, University of Oxford
Open access
Protocol CitationKorvus Wang, michael fairhead, Eleanor Williams 2024. Enterovirus D68 3C protease small scale expression and purification protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.dm6gpzrkdlzp/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: April 18, 2024
Last Modified: April 26, 2024
Protocol Integer ID: 98385
Keywords: 3C proteases, enterovirusses, IMAC, ASAP, CMD, protein purification
Funders Acknowledgement:
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
Grant ID: U19AI171432
Disclaimer
Research was supported in part by NIAID of the U.S National Institutes of Health under award number U19AI171399. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Abstract
This protocol details the expression and purification of enterovirus D68 3C protease construct bearing a C-terminal His-tag at small scale (<6L).
Guidelines
  • Construct / plasmid resource-name: Enterovirus D68 3C protease construct bearing a C-terminal His-tag that crystallised in the space group P212121

  • Brief description of the plasmid: This protein yielded highly reproducible crystals upon microseeding, which typically diffracted to 1.7 Å resolution. This crystal system was DMSO tolerant and therefore suitable for our subsequent fragment soaking.

  • Provided Date: 2022-03-24
Materials
Plasmid details:
Addgene plasmid #204817
  • Vector: pNIC
  • Cell line: E. coli Rosetta strain BL21(DE3)-RR
  • Tags and additions: C-terminal, non-cleavable hexahistidine
  • Construct protein sequence: ` MGPGFDFAQAIMKKNTVIARTEKGEFTMLGVYDRVAVIPTHASVGEIIYINDVETRVLDACALRDLTDTNLEITIVKLDRNQKFRDIRHFLPRCEDDYNDAVLSVHTSKFPNMYIPVGQVTNYGFLNLGGTPTHRILMYNFPTRAGQCGGVVTTTGKVIGIHVGGNGAQGFAAMLLHSYFTDTQKHHHHHH

Expression
AIM-TB: TB autoinduction media (Formedium AIMTB0210)

Purification
Chicken hen egg white lysozyme (Merck, 62971)
Benzonase (Merck, 1.01654)
Imidazole (Merck, RDD044)
Ni Sepharose 6 FF resin (Cytiva, 17531801)
Gravity flow column, 2.5cm diameter (Bio Rad, 7372532)
Centrifugal concentrators, 10kDa MWCO (Merck, UFC901008)

On an FPLC system:
SEPAX SEC SRT-100 (Sepax Tech, 215100-21230)
or
HiLoad 16/600 Superdex 75 pg (Cytiva, 28989333)

5mL sample loop

SDS-PAGE sample buffer, gel, and gel tank

Lysis buffer:

AB
Hepes (pH 7.5)50 mM
NaCl500 mM
Glycerol5%
Imidazole20 mM
TCEP0.5 mM
TX-1001%
Lysozyme0.5 mg/mL
Benzonase0.05 mg/mL
Prepare 100 mL per 1 L E.coli expression


Base buffer:
AB
Hepes (pH 7.5)50 mM
NaCl500 mM
Glycerol5%
TCEP0.5 mM
Prepare 2 L per 6 L E.coli expression. Used to prepare the following buffers
Binding buffer: base buffer, add 30mM imidazole
Wash buffer: base buffer, add 30mM imidazole
Elution buffer: base buffer, add 500mM imidazole
Gel filtration buffer: same as base buffer

SDS-PAGE: NuPage 4-12%, Bis-Tris protein gel, 26 well (Thermo-Fisher, WG1403BOX)
Run in MES buffer, 200V 35mins.







Abbreviations
Abbreviations
CV - column volume, total volume of resin in a column
IMAC - immobilised metal affinity chromatography
D68EV3C - Enterovirus D68 3C protease
Plasmid Transformation
Plasmid Transformation
1d
Transform the D68EV3C construct (Addgene plasmid #204817) into BL21(DE3) and store a glycerol stock of this at Temperature-80 °C
Note
The D68EV3C construct encodes the 3C protease with a non-cleavable C-terminal his tag on a kanamycin resistant plasmid backbone with a T7 promoter.

Protein expression
Protein expression
2d 10h
Scrape off some of the glycerol stock with a sterile loop and use this to inoculate a 50 mL falcon tube containing Amount10 mL of LB supplemented with Concentration50 ug/mL kanamycin. Grow the starter culture at Temperature37 °C DurationOvernight with 200 rpm shaking.
1d
Use the Amount10 mL starter culture to inoculate Amount1 L SampleSample (see Materials) supplemented with Concentration50 ug/mL kanamycin in a baffled flask. Shaker250 rpm, 37°C

Note
For this protocol typically 2 L of culture is grown for each purification

6h
When the OD600 reaches approximately 4.0, lower the temperature and shaker speed to Shaker200 rpm, 18°C and incubate Duration24:00:00
1d
Overnight
Harvest the cells by centrifugation at Centrifigation5000 x g, 4°C, 00:30:00 . Discard supernatant and store pellet at Temperature-80 °C .
30m
Protein Purifcation
Protein Purifcation
2d
Lyse cell pellet
2h 30m

Note
See Materials tab for buffer compositions.


Note
D68EV3C construct protein properties
MW = 21.283 kDa
Extinction coefficient (assume all Cys reduced)=10430 mM-1cm-1
pI = 7.21

Values determined using Expasy ProtParam


Thaw and resuspend the pellet in ~7mL of lysis buffer per g of pellet. Stir gently with a magnetic stir bar at TemperatureRoom temperature for Duration00:30:00 to allow lysozyme, benzonase and Triton X-100 to start breaking down cell components.
1h
Store the homogenised lysate at Temperature-80 °C and then thaw in a room temperature water bath to further lyse the cells, freeze-thaw.

Centrifuge the lysed cells Centrifigation38000 x g, 4°C, 01:00:00 to remove insoluble cell debris, and collect the supernatant Temperature4 °C
1h
Perform IMAC to extract target protein from the lysed cell mixture
Dispense Amount10 mL Nickle affinity resin (Ni Sepharose 6 FF, Cytiva) into a gravity flow column.
Wash the resin first with ~ Amount20 CV distilled water to remove the storage solution and then ~ Amount20 CV binding buffer to equilibrate
10m
Pour the clarified supernatant over the equilibrated resin and allow to flow though. This will allow the His-tagged target protein to bind onto the Ni ions in the resin.
Retain the flow through separately for SDS-PAGE analysis.
Wash the column with Amount10 CV of wash buffer twice. Allow wash buffer to pass through completely between washes. This is to remove non-specific, weak binding of contaminant proteins from the resin for a cleaner elution.
Collect washes separately for SDS-PAGE analysis.
30m
Elute the protein with Amount1.5 CV of elution buffer.
20m
Repeat step 7.5 a further 2 times, collecting a total of 3 separate elution fractions. This is to ensure maximum retrieval of protein from the resin.
Measured the A280 values of the elution fractions to estimate the protein content
For example:
E1: A280=5.69
E2: A280=10.1
E3: A280=4.23
20m
Run SDS-PAGE of all samples from total lysis supernatant to final elution. Stain gel with Coomasssie Blue and determine which fractions contain the target protein by finding the band corresponding to the target molecular weight, 21.3 kDa.

Note
The target protein is expected to be present mostly in the elution samples, although small amounts may be found in the flow through and washes.
If that is not the case, then further troubleshooting is required.

SDS-PAGE analysis of IMAC fractions. The thick protein band observed in all three elutions agree with the calculated molecular weight of D68EV3C protease, 21.3 kDa.
SDS-PAGE analysis of IMAC fractions. The thick protein band observed in all three elutions agree with the calculated molecular weight of D68EV3C protease, 21.3 kDa.

40m
Purify sample further by size exclusion chromatography.
Pool and concentration all elution fractions to a final volume of under Amount5 mL using a 10 kDa MWCO centrifugal concentrator

Remove any solid aggregates from the sample by centrifugation at Centrifigation17200 x g, 4°C, 00:10:00 , then immediately draw up the supernatant with a 5mL syringe and a blunt-tip fill needle, taking care not to disturb the pellet.

Note
This is to remove as much solid particles from the injection sample as possible, so as to not clog the in-line filter or frit of the column.


10m
Using an AKTA Pure FPLC system or equivalent:

Inject the sample onto a 5mL sample loop.

Run the sample down Sepax SRT SEC-100 gel filtration column at 7.5mL/min in gel filtration buffer, collecting 1mL fractions in 96 well deep-well blocks.
The column should be pre-equilibrated in SEC buffer.

Note
Here a SEPAX SEC SRT-100 column was used due to availability, however other columns would also be suitable such as a Superdex 75 16/60 (Cytiva)


Run the peak SEC fractions on SDS PAGE to assess purity.

For example:
Chromatogram of the SEC run. Fractions D10-F6 were analyse by SDS-PAGE to determine which contained the target protein.
Chromatogram of the SEC run. Fractions D10-F6 were analyse by SDS-PAGE to determine which contained the target protein.

SDS-PAGE analysis of SEC fractions D10-F6. Fractions E6-F6 were pooled as they contain majority target protein in comparison to contaminants.
SDS-PAGE analysis of SEC fractions D10-F6. Fractions E6-F6 were pooled as they contain majority target protein in comparison to contaminants.

40m
Take the fractions that contain the cleanest target protein and concentrate toConcentration21 mg/mL using a 10 kDa MWCO centrifugal concentrator

Take Amount1 µL of the final sample for SDS-PAGE, and another for mass spectroscopy.


Intact Mass-spectrometry of purified D68EV3C protease sample. Mass spec result showing the purified D68EV3C protease has the expected molecular weight, 21.283 kDa
Intact Mass-spectrometry of purified D68EV3C protease sample. Mass spec result showing the purified D68EV3C protease has the expected molecular weight, 21.283 kDa



2h
Aliquot into appropriate volumes for future usage to minimise freeze/thaw cycles. Flash-freeze in liquid nitrogen, and store at Temperature-80 °C until required.
For example:
The final yield from processing 2 L of cells was 128 mg of pure D68 EV 3C protease